Table of Contents Europe Overactive Bladder Therapeutics Market Report 2012-2023 1 Overactive Bladder Therapeutics Overview 1.1 Product Overview and Scope of Overactive Bladder Therapeutics 1.2 Classification of Overactive Bladder Therapeutics by Product Category 1.2.1 Europe Overactive Bladder Therapeutics Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Overactive Bladder Therapeutics Sales (K Units) Market Share by Types in 2017 1.2.3 Anti-Muscarinic Agent 1.2.4 Beta-3-Adrenergic Receptor Agonist 1.2.5 Others 1.3 Europe Overactive Bladder Therapeutics Market by Application/End Users 1.3.1 Europe Overactive Bladder Therapeutics (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Medical Care 1.3.3 Medical Research 1.3.4 Others 1.4 Europe Overactive Bladder Therapeutics Market by Region 1.4.1 Europe Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Overactive Bladder Therapeutics (2012-2023) 1.5.1 Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Overactive Bladder Therapeutics 2.2 Raw Material Analysis of Overactive Bladder Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Overactive Bladder Therapeutics 2.4 Other Costs Analysis of Overactive Bladder Therapeutics 2.5 Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics 2.6 Manufacturing Process Analysis of Overactive Bladder Therapeutics 2.7 Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Overactive Bladder Therapeutics Players/Suppliers Profiles and Sales Data 3.1 Actavis 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Actavis Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Actavis Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.2 Allergan 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Allergan Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Allergan Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.3 Astellas Pharma 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Astellas Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Astellas Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.4 Pfizer 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Pfizer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Pfizer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.5 Addex Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Addex Pharmaceuticals Ltd Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.6 Bayer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Bayer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Bayer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.7 Elbion 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Elbion Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Elbion Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.8 Ipsen 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Ipsen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Ipsen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.9 Janssen 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Janssen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Janssen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.10 Kissei Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Kissei Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Kissei Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 4 Europe Overactive Bladder Therapeutics Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Overactive Bladder Therapeutics Market Competition by Players/Manufacturers 4.1.1 Europe Overactive Bladder Therapeutics Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Overactive Bladder Therapeutics Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Overactive Bladder Therapeutics Sales and Revenue by Type 4.2.1 Europe Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Overactive Bladder Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Overactive Bladder Therapeutics Sales and Revenue by Application 4.3.1 Europe Overactive Bladder Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Overactive Bladder Therapeutics Sales (K Units) by Application 5 Germany Overactive Bladder Therapeutics (Sales, Revenue and Price) 5.1 Germany Overactive Bladder Therapeutics Sales and Value (2012-2017) 5.1.1 Germany Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 Germany Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 5.3 Germany Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 6 UK Overactive Bladder Therapeutics (Sales, Revenue and Price) 6.1 UK Overactive Bladder Therapeutics Sales and Value (2012-2017) 6.1.1 UK Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 UK Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 6.3 UK Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 7 France Overactive Bladder Therapeutics (Sales, Revenue and Price) 7.1 France Overactive Bladder Therapeutics Sales and Value (2012-2017) 7.1.1 France Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 France Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 7.3 France Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 8 Russia Overactive Bladder Therapeutics (Sales, Revenue and Price) 8.1 Russia Overactive Bladder Therapeutics Sales and Value (2012-2017) 8.1.1 Russia Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 Russia Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 8.3 Russia Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 9 Benelux Overactive Bladder Therapeutics (Sales, Revenue and Price) 9.1 Benelux Overactive Bladder Therapeutics Sales and Value (2012-2017) 9.1.1 Benelux Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 9.3 Benelux Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 10 Italy Overactive Bladder Therapeutics (Sales, Revenue and Price) 10.1 Italy Overactive Bladder Therapeutics Sales and Value (2012-2017) 10.1.1 Italy Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 10.1.3 Italy Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 10.3 Italy Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 11 Spain Overactive Bladder Therapeutics (Sales, Revenue and Price) 11.1 Spain Overactive Bladder Therapeutics Sales and Value (2012-2017) 11.1.1 Spain Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 11.1.3 Spain Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 11.3 Spain Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Overactive Bladder Therapeutics Market Forecast (2018-2023) 13.1 Europe Overactive Bladder Therapeutics Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Overactive Bladder Therapeutics Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) 13.2 Europe Overactive Bladder Therapeutics Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Overactive Bladder Therapeutics Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Overactive Bladder Therapeutics Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Overactive Bladder Therapeutics Sales Forecast by Type (2018-2023) 13.3.2 Europe Overactive Bladder Therapeutics Revenue Forecast by Type (2018-2023) 13.3.3 Europe Overactive Bladder Therapeutics Price Forecast by Type (2018-2023) 13.4 Europe Overactive Bladder Therapeutics Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Overactive Bladder Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Overactive Bladder Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Overactive Bladder Therapeutics Table Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Overactive Bladder Therapeutics Sales (K Units) Market Share by Types in 2017 Figure Anti-Muscarinic Agent Picture Figure Beta-3-Adrenergic Receptor Agonist Picture Figure Others Picture Table Europe Overactive Bladder Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Overactive Bladder Therapeutics by Applications in 2017 Figure Medical Care Picture Figure Medical Research Picture Figure Others Picture Table Europe Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure France Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Overactive Bladder Therapeutics Table Industry News List of Overactive Bladder Therapeutics Figure Industry Chain Structure of Overactive Bladder Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics in 2017 Figure Manufacturing Process Analysis of Overactive Bladder Therapeutics Table Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers Europe Table Major Buyers of Overactive Bladder Therapeutics Table Actavis Basic Information List Table Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Actavis Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Allergan Basic Information List Table Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Allergan Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Astellas Pharma Basic Information List Table Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Pfizer Basic Information List Table Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Addex Pharmaceuticals Ltd Basic Information List Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Bayer Basic Information List Table Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Elbion Basic Information List Table Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Elbion Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Ipsen Basic Information List Table Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Ipsen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Janssen Basic Information List Table Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Company Kissei Pharma Basic Information List Table Company Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Sales Europe Market Share (%) (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Revenue Europe Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Europe Overactive Bladder Therapeutics Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Overactive Bladder Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Overactive Bladder Therapeutics Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Overactive Bladder Therapeutics Sales Share by Players/Manufacturers Table Europe Overactive Bladder Therapeutics Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Overactive Bladder Therapeutics Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Overactive Bladder Therapeutics Revenue Market Share (%) Players Figure 2017 Europe Overactive Bladder Therapeutics Revenue Market Share (%) Players Table Europe Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Overactive Bladder Therapeutics Sales Share by Type (2012-2017) Figure Sales Market Share of Overactive Bladder Therapeutics by Type (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales Growth Rate (%) by Type (2012-2017) Table Europe Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Overactive Bladder Therapeutics Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Overactive Bladder Therapeutics by Type (2012-2017) Figure Europe Overactive Bladder Therapeutics Revenue Growth Rate by Type (2012-2017) Table Europe Overactive Bladder Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Overactive Bladder Therapeutics Sales Share by Regions (2012-2017) Figure Sales Market Share of Overactive Bladder Therapeutics by Regions (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales Market Share by Regions in 2017 Table Europe Overactive Bladder Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Overactive Bladder Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Overactive Bladder Therapeutics by Regions (2012-2017) Figure Europe Overactive Bladder Therapeutics Revenue Market Share by Regions in 2017 Table Europe Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application (2012-2017) Table Europe Overactive Bladder Therapeutics Sales Share (%) by Application (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales Market Share by Application (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales Market Share by Application (2012-2017) Figure Germany Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Germany Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Germany Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Germany Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Germany Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Germany Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure UK Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure UK Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table UK Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table UK Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure UK Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table UK Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table UK Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure UK Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure France Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure France Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table France Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table France Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure France Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table France Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table France Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure France Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Russia Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Russia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Russia Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Russia Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Russia Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Russia Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Russia Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Italy Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Italy Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Italy Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Italy Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Italy Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Italy Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Italy Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Benelux Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Benelux Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Benelux Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Benelux Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Spain Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Spain Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Spain Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Spain Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Spain Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Spain Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Spain Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) Table Europe Overactive Bladder Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Overactive Bladder Therapeutics Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Overactive Bladder Therapeutics Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Overactive Bladder Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Overactive Bladder Therapeutics Revenue Market Share Forecast by Regions in 2023 Figure Germany Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Overactive Bladder Therapeutics Sales (K Units) Forecast by Type (2018-2023) Figure Europe Overactive Bladder Therapeutics Sales Market Share Forecast by Type (2018-2023) Table Europe Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Overactive Bladder Therapeutics Revenue Market Share Forecast by Type (2018-2023) Table Europe Overactive Bladder Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Overactive Bladder Therapeutics Sales (K Units) Forecast by Application (2018-2023) Figure Europe Overactive Bladder Therapeutics Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actavis Allergan Astellas Pharma Pfizer Addex Pharmaceuticals Ltd Bayer Elbion Ipsen Janssen Kissei Pharma